Pharmaceutical Federation (02268) rose more than 6% and rose 6.57% at press time to report HK$18.16, with a turnover of HK$18.65 million.
The Zhitong Finance App learned that Yao Ming United (02268) rose by more than 6% and rose 6.57% at press time to HK$18.16, with a turnover of HK$18.65 million.
According to the news, Yao Ming Union recently announced its 2023 annual results. The group obtained revenue of RMB 2,124 billion (same unit), an increase of 114.4% over the previous year; net profit attributable to company owners was 284 million yuan, an increase of 82.1% over the previous year; and adjusted net profit increased strongly by 112% to 412 million yuan. Basic profit per share was $0.28. Furthermore, the number of integrated projects rose to 143, and 50 new integrated projects were signed in 2023.
BOC International said that considering the continued growth of the company's large orders in the later stages and the certainty of fulfilling high performance growth expectations, the current stock price is still significantly undervalued, maintaining the company's “buy” rating. Dongwu Securities pointed out that the number of projects at all stages of the company has maintained rapid growth, and is expected to usher in commercialization projects in 2024, and the company has ongoing orders of 579 million US dollars (+81.9%) by 2023. With the discovery of new ADC targets and the development of dual anti-ADC, ADC combination therapy, and XDC, the ADC industry is expected to maintain a high boom, driving the company's high performance growth.